Development and validation of a novel patient-reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine Diary

CONCLUSION: The AIM-D is a content valid and psychometrically sound measure designed to evaluate activity impairment and is suitable for use in clinical trials of preventive treatments for EM or CM.PMID:34962305 | DOI:10.1111/head.14229

Source: Headache - December 28, 2021 Category: Neurology Authors: Richard B Lipton Pranav Gandhi Jonathan Stokes Mary Lynn Cala Christopher J Evans Naomi Knoble Heather L Gelhorn Dennis Revicki Hema N Viswanathan David W Dodick Source Type: research